"Anti-Retroviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat RETROVIRIDAE INFECTIONS.
| Descriptor ID |
D044966
|
| MeSH Number(s) |
D27.505.954.122.388.077
|
| Concept/Terms |
Anti-Retroviral Agents- Anti-Retroviral Agents
- Agents, Anti-Retroviral
- Anti Retroviral Agents
- Antiretroviral Agents
- Agents, Antiretroviral
|
Below are MeSH descriptors whose meaning is more general than "Anti-Retroviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Retroviral Agents".
This graph shows the total number of publications written about "Anti-Retroviral Agents" by people in this website by year, and whether "Anti-Retroviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 3 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 2 | 4 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 2 | 4 |
| 2013 | 10 | 2 | 12 |
| 2014 | 8 | 1 | 9 |
| 2015 | 5 | 1 | 6 |
| 2016 | 6 | 2 | 8 |
| 2017 | 1 | 3 | 4 |
| 2018 | 7 | 2 | 9 |
| 2019 | 4 | 3 | 7 |
| 2020 | 2 | 2 | 4 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Retroviral Agents" by people in Profiles.
-
Low-level viraemia as a risk factor for virologic failure in children and adolescents living with HIV on antiretroviral therapy in Tanzania: a multicentre, retrospective cohort study. J Int AIDS Soc. 2025 May; 28(5):e26474.
-
Attitudes and Barriers Toward Antiretroviral Therapeutic Drug Monitoring Among Infectious Disease Providers. Medicina (Kaunas). 2025 Mar 20; 61(3).
-
Viral load suppression and retention in care among children and adolescents receiving multi-month anti-retroviral therapy refills: a program data review in Uganda. BMC Pediatr. 2024 Dec 07; 24(1):804.
-
Trends and disparities in antiretroviral therapy prescription rates among US Medicare beneficiaries with HIV. HIV Med. 2025 Mar; 26(3):415-426.
-
Past-Year HIV Testing, Current Antiretroviral Therapy Use, and Participation in Services for People Who Inject Drugs. AIDS Behav. 2024 Aug; 28(8):2793-2803.
-
Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature. Curr HIV/AIDS Rep. 2024 02; 21(1):1-10.
-
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques. J Control Release. 2024 02; 366:18-27.
-
Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis. PLoS One. 2023; 18(6):e0276473.
-
MyTPill: study protocol for a cross-over randomised controlled trial comparing novel strategies to monitor antiretroviral adherence among HIV+ prescription opioid users. BMJ Open. 2023 01 10; 13(1):e062805.
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.